Other UK biotech could be bound for recovery, BIA report reveals Pharmaceutical TechnologyWith an uptick and increasingly even spread of capital across the space, the BIA's Martin Turner is optimistic for British biotech's future.Read full story pharminent April 27, 2026 (Last updated: April 27, 2026) Pharmaceutical Technology With an uptick and increasingly even spread of capital across the space, the BIA’s Martin Turner is optimistic for British biotech’s future. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: UK medicines regulator grants marketing authorisation to Enflonsia for RSV preventionNext: Lilly falls on slower start for Foundayo versus Wegovy Related Stories Other ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer pharminent June 2, 2026 Other ASCO26: Symptom-tracking app helps advanced cancer patients pharminent June 2, 2026 Other All eyes on Revolution, bispecific antibodies and more at ASCO26 pharminent May 26, 2026
